Gingival Recession Market is segmented By Treatment Method (Soft Tissue Grafting, Regenerative Proce...
Market Size in USD Bn
CAGR5.66%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 5.66% |
Market Concentration | High |
Major Players | Straumann Group, Dentsply Sirona, Geistlich Pharma, Zimmer Biomet Dental, BioHorizons and Among Others |
The gingival recession market is estimated to be valued at USD 3.36 Bn in 2024 and is expected to reach USD 4.94 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.66% from 2024 to 2031. The aging global population is more prone to gum diseases such as gingivitis and periodontitis, driving the need for treatments of gingival recession. Furthermore, the growing awareness about oral healthcare and rising disposable incomes are also contributing to the growth of this market.